Exelixis (EXEL) Enterprise Value (2010 - 2026)
Exelixis (EXEL) recorded quarterly Enterprise Value of -$777.2 million in Q2 2026, up 26.62% quarter-over-quarter from -$1.1 billion in Q1 2026, and up 24.64% on a YoY basis from -$623.6 million in Q2 2025.
Exelixis (EXEL) Enterprise Value (2010 - 2026) Analysis & Trends
Exelixis' Enterprise Value history runs 17 years deep, the most recent figure standing at -$777.2 million for Q2 2026.
- In Q2 2026, Enterprise Value rose 24.64% year-over-year to -$777.2 million; the TTM figure through Apr 2026 stood at -$777.2 million (up 24.64% YoY), while the FY2026 annual figure was -$1.1 billion, up 4.7% from the prior year.
- Enterprise Value was -$777.2 million for Q2 2026 at Exelixis, up from -$1.1 billion in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$777.2 million in Q2 2026 to a low of -$1.6 billion in Q2 2022.
- Historically, Enterprise Value has averaged -$1.2 billion across 5 years, with a median of -$1.1 billion in 2023.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value sank 32.46% in 2022, then gained 28.68% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$1.3 billion in 2022, then increased by 23.93% to -$995.3 million in 2023, then decreased by 19.48% to -$1.2 billion in 2024, then advanced by 16.87% to -$988.5 million in 2025, then climbed by 21.38% to -$777.2 million in 2026.
- The last three Enterprise Value figures came in at -$777.2 million (Q2 2026), -$1.1 billion (Q1 2026), and -$988.5 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -584.73 Mn |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn | -777.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -777.21 Mn |
| Jan 2, 2026 | -1.06 Bn |
| Oct 3, 2025 | -988.54 Mn |
| Jul 4, 2025 | -791.10 Mn |
| Apr 4, 2025 | -1.03 Bn |
| Jan 3, 2025 | -1.11 Bn |
| Sep 27, 2024 | -1.19 Bn |
| Jun 28, 2024 | -1.00 Bn |
| Mar 29, 2024 | -963.26 Mn |
| Dec 29, 2023 | -995.30 Mn |
| Sep 29, 2023 | -1.10 Bn |
| Jun 30, 2023 | -1.27 Bn |
| Mar 31, 2023 | -1.31 Bn |
| Dec 30, 2022 | -1.31 Bn |
| Sep 30, 2022 | -1.55 Bn |
| Jul 1, 2022 | -1.53 Bn |
| Apr 1, 2022 | -1.57 Bn |
| Dec 31, 2021 | -1.47 Bn |
| Oct 1, 2021 | -1.40 Bn |
| Jul 2, 2021 | -1.35 Bn |